Development of a palliative score in inpatients with advanced tumor disease (PaSco study)

Recruiting

• Conditions: C50; C32; Malignant neoplasm of breast; Malignant neoplasm of larynx

• Registration Number: DRKS00023723
• Lead Sponsor: Interdisziplinäres Zentrum Palliativmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-07
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Pancreatic carcinoma
gynecological tumor
urological tumor
dermatological tumor
ENT tumor
in stage UICC III or IV

Exclusion Criteria

lack of speech comprehension
Karnofsky index < 20%

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of a palliative score that identifies inpatients with SPC needs.<br>The palliative score is comprised of the prognosis-relevant information from the nursing history (palliative screening), the IPOS (Integrated palliative care outcome scale) and the doctor's assessment (modified glare tool). The automatically collected, prognosis-relevant data from the nursing history, the patient's self-assessment and the physician's assessment are to be combined to generate the palliative score.